These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 24721464)

  • 1. Evaluation of multiple measures of antiretroviral adherence in the Eastern European country of Georgia.
    Chkhartishvili N; Rukhadze N; Svanidze M; Sharvadze L; Dehovitz JA; Tsertsvadze T; McNutt LA; del Rio C
    J Int AIDS Soc; 2014; 17(1):18885. PubMed ID: 24721464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting viral load suppression by self-reported adherence, pharmacy refill counts and real time medication monitoring among people living with HIV in Tanzania.
    Ngowi KM; Minja L; Boer IMS; Aarnoutse RE; Masika L; Sprangers MAG; Pima FM; Mmbaga BT; Reiss P; Nieuwkerk PT
    AIDS Res Ther; 2022 Nov; 19(1):51. PubMed ID: 36380383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which adherence measure - self-report, clinician recorded or pharmacy refill - is best able to predict detectable viral load in a public ART programme without routine plasma viral load monitoring?
    Mekuria LA; Prins JM; Yalew AW; Sprangers MA; Nieuwkerk PT
    Trop Med Int Health; 2016 Jul; 21(7):856-69. PubMed ID: 27118068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacy refill adherence outperforms self-reported methods in predicting HIV therapy outcome in resource-limited settings.
    Sangeda RZ; Mosha F; Prosperi M; Aboud S; Vercauteren J; Camacho RJ; Lyamuya EF; Van Wijngaerden E; Vandamme AM
    BMC Public Health; 2014 Oct; 14():1035. PubMed ID: 25280535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of an adherence program to antiretroviral treatment on virologic response in a cohort of multitreated and poorly adherent HIV-infected patients in Spain.
    Navarro J; Pérez M; Curran A; Burgos J; Feijoo M; Torrella A; Caballero E; Ocaña I; Ribera E; Crespo M; Falcó V
    AIDS Patient Care STDS; 2014 Oct; 28(10):537-42. PubMed ID: 25111167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of six methods to estimate adherence in an ART-naïve cohort in a resource-poor setting: which best predicts virological and resistance outcomes?
    Orrell C; Cohen K; Leisegang R; Bangsberg DR; Wood R; Maartens G
    AIDS Res Ther; 2017 Apr; 14(1):20. PubMed ID: 28376815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Socio-Demographic and Adherence Factors Associated with Viral Load Suppression in HIV-Infected Adults Initiating Therapy in Northern Nigeria: A Randomized Controlled Trial of a Peer Support Intervention.
    Coker M; Etiebet MA; Chang H; Awwal G; Jumare J; Musa BM; Babashani M; Habib AG; Dakum P; Abimiku AG; Charurat ME; Blattner WA; Eng M; Ndembi N
    Curr HIV Res; 2015; 13(4):279-85. PubMed ID: 25845393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to On-Time ART Drug Pick-Up and Its Association with CD4 Changes and Clinical Outcomes Amongst HIV Infected Adults on First-Line Antiretroviral Therapy in Nigerian Hospitals.
    Anoje C; Agu KA; Oladele EA; Badru T; Adedokun O; Oqua D; Khamofu H; Adebayo O; Torpey K; Chabikuli ON
    AIDS Behav; 2017 Feb; 21(2):386-392. PubMed ID: 27388161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacy refill data can be used to predict virologic failure for patients on antiretroviral therapy in Brazil.
    Martin D; Luz PM; Lake JE; Clark JL; Campos DP; Veloso VG; Moreira RI; Cardoso SW; Klausner JD; Grinsztejn B
    J Int AIDS Soc; 2017 Jun; 20(1):21405. PubMed ID: 28605172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virologic outcomes of second-line antiretroviral therapy in Eastern European country of Georgia.
    Chkhartishvili N; Sharvadze L; Dvali N; Karchava M; Rukhadze N; Lomtadze M; Chokoshvili O; Tsertsvadze T
    AIDS Res Ther; 2014; 11():18. PubMed ID: 25035708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-Report Measures in the Assessment of Antiretroviral Medication Adherence: Comparison with Medication Possession Ratio and HIV Viral Load.
    Kabore L; Muntner P; Chamot E; Zinski A; Burkholder G; Mugavero MJ
    J Int Assoc Provid AIDS Care; 2015; 14(2):156-62. PubMed ID: 25421930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol use and viral suppression in HIV-positive Kenyan female sex workers on antiretroviral therapy.
    Long JE; Richardson BA; Wanje G; Wilson KS; Shafi J; Mandaliya K; Simoni JM; Kinuthia J; Jaoko W; McClelland RS
    PLoS One; 2020; 15(11):e0242817. PubMed ID: 33232378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics associated with virologic failure in high-risk HIV-positive participants with prior failure: a post hoc analysis of ACTG 5251.
    Robbins GK; Cohn SE; Harrison LJ; Smeaton L; Moran L; Rusin D; Dehlinger M; Flynn T; Lammert S; Wu AW; Safren SA; Reynolds NR
    HIV Clin Trials; 2016 Jul; 17(4):165-72. PubMed ID: 27347650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Universal test and treat is not associated with sub-optimal antiretroviral therapy adherence in rural South Africa: the ANRS 12249 TasP trial.
    Iwuji C; McGrath N; Calmy A; Dabis F; Pillay D; Newell ML; Baisley K; Porter K
    J Int AIDS Soc; 2018 Jun; 21(6):e25112. PubMed ID: 29890048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple self-reported adherence tool as a predictor of viral rebound in people with viral suppression on antiretroviral therapy.
    O'Connor JL; Gardner EM; Esser S; Mannheimer SB; Lifson AR; Telzak EE; Phillips AN;
    HIV Med; 2016 Feb; 17(2):124-32. PubMed ID: 26186609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short term adherence tool predicts failure on second line protease inhibitor-based antiretroviral therapy: an observational cohort study.
    Court R; Leisegang R; Stewart A; Sunpath H; Murphy R; Winternheimer P; Ally M; Maartens G
    BMC Infect Dis; 2014 Dec; 14():664. PubMed ID: 25472544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with suboptimal adherence to antiretroviral therapy in Asia.
    Jiamsakul A; Kumarasamy N; Ditangco R; Li PC; Phanuphak P; Sirisanthana T; Sungkanuparph S; Kantipong P; K C Lee C; Mustafa M; Merati T; Kamarulzaman A; Singtoroj T; Law M;
    J Int AIDS Soc; 2014; 17(1):18911. PubMed ID: 24836775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-calibration of two self-reported measures of adherence to antiretroviral therapy.
    Nance RM; Delaney JA; Golin CE; Wechsberg WM; Cunningham C; Altice F; Christopoulos K; Knight K; Quan V; Gordon MS; Springer S; Young J; Crane PK; Mayer KH; Mugavero MJ; Del Rio C; Kronmal RA; Crane HM
    AIDS Care; 2017 Apr; 29(4):464-468. PubMed ID: 27910703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy.
    Bisson GP; Gross R; Bellamy S; Chittams J; Hislop M; Regensberg L; Frank I; Maartens G; Nachega JB
    PLoS Med; 2008 May; 5(5):e109. PubMed ID: 18494555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.